Dow Jones

39 118,86

-0,12%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Endocyte, Inc. (delisted) (ECYT)
Endocyte, Inc. (delisted) (ECYT) Actualités

ECYT

Endocyte, Inc. (delisted) (ECYT)

Endocyte, Inc. (delisted)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ECYT

1 2 3 4 5 6 7 8 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
14/02/2019	23h25	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
31/12/2018	16h37	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
27/12/2018	12h02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
21/12/2018	18h57	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
21/12/2018	17h56	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
21/12/2018	17h51	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
21/12/2018	17h47	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
21/12/2018	14h47	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:ECYT	Endocyte, Inc. (delisted)
20/12/2018	15h44	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
20/12/2018	15h25	GlobeNewswire Inc.	Endocyte Stockholders Approve Merger Agreement with Novartis AG	NASDAQ:ECYT	Endocyte, Inc. (delisted)
12/12/2018	22h17	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
16/11/2018	12h20	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
15/11/2018	22h19	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
08/11/2018	18h25	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
07/11/2018	22h01	GlobeNewswire Inc.	Endocyte Provides Third Quarter 2018 Financial Results and Operational Update	NASDAQ:ECYT	Endocyte, Inc. (delisted)
06/11/2018	23h37	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
01/11/2018	15h33	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
31/10/2018	22h31	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (prem14a)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
19/10/2018	09h02	Dow Jones News	Novartis Deal Reflects Stress on High-Value Drugs -- WSJ	NASDAQ:ECYT	Endocyte, Inc. (delisted)
18/10/2018	17h36	Dow Jones News	These Guys Should Start a Hedge Fund	NASDAQ:ECYT	Endocyte, Inc. (delisted)
18/10/2018	14h50	Dow Jones News	Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion -- 3rd Update	NASDAQ:ECYT	Endocyte, Inc. (delisted)
18/10/2018	10h40	Dow Jones News	Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion -- 2nd Update	NASDAQ:ECYT	Endocyte, Inc. (delisted)
18/10/2018	09h35	Dow Jones News	Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion -- Update	NASDAQ:ECYT	Endocyte, Inc. (delisted)
18/10/2018	07h58	Dow Jones News	Novartis Raises Outlook, Announces Endocyte Acquisition	NASDAQ:ECYT	Endocyte, Inc. (delisted)
18/10/2018	07h10	GlobeNewswire Inc.	Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion	NASDAQ:ECYT	Endocyte, Inc. (delisted)
16/10/2018	22h22	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:ECYT	Endocyte, Inc. (delisted)
03/10/2018	12h00	GlobeNewswire Inc.	Endocyte becomes first Purdue startup to reach $1.5B in value	NASDAQ:ECYT	Endocyte, Inc. (delisted)
27/09/2018	14h01	GlobeNewswire Inc.	Endocyte to Present at Two Investor Conferences on October 2nd	NASDAQ:ECYT	Endocyte, Inc. (delisted)
14/09/2018	22h01	GlobeNewswire Inc.	Endocyte Announces Closing of Public Offering of Common Stock	NASDAQ:ECYT	Endocyte, Inc. (delisted)
12/09/2018	22h05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ECYT	Endocyte, Inc. (delisted)